| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Oncology, Department of Medicine, Neil Hellman Medical Research Building, Albany Medical College, Albany, New York 12208 [W. P. T., D. B. L.], and Laboratory of Molecular Pharmacology, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20205 [K. W. K.]
The modification of DNA by the haloethylnitrosoureas is probably responsible for their antitumor activity. A current hypothesis relates this cytotoxic action to the transfer of haloethyl groups from the nitrosourea to DNA followed by a second reaction of the haloethyl group with the opposite DNA strand. However, other modifications besides interstrand cross-links are introduced into DNA, raising the question whether the choice of the particular nitrosourea could affect the distribution of DNA modifications in a way which would maximize cytotoxic activity.
To investigate this point, DNA was reacted with the following compounds: N,N'-bis(2-chloroethyl)-N-nitrosourea (NSC 409962); N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea (NSC 79037); N-(2-chloroethyl)-N'-(2,6-dihydroxycyclohexyl)-N-nitrosourea (NSC 264395); N-(2-chloroethyl)-N-nitrosourea (NSC 47547); and N-(2-fluoroethyl)-N'-cyclohexyl-N-nitrosourea (NSC 87974). Reacted DNA was depurinated, and the distribution of guanine derivatives was obtained by high-pressure liquid chromatography.
These studies have shown that the distribution of products obtained is markedly influenced by the chemical structure of the nitrosourea. Differences are noted in the relative amounts of 6- versus 7-substituted guanines, in the amount of hydroxyethylation versus haloethylation, and in the amount of diguanylethane formation. Thus, it may be possible to modulate the biological effect obtained from a nitrosourea by changing its molecular structure.
1 Supported by Order 263-MD-132928 from the National Cancer Institute.
2 To whom requests for reprints should be addressed.
Received 4/22/82. Accepted 8/ 6/82.
This article has been cited by other articles:
![]() |
P. L. Fischhaber, A. S. Gall, J. A. Duncan, and P. B. Hopkins Direct Demonstration in Synthetic Oligonucleotides that N,N'-Bis(2-chloroethyl)-nitrosourea Cross-Links N1 of Deoxyguanosine to N3 of Deoxycytidine on Opposite Strands of Duplex DNA Cancer Res., September 1, 1999; 59(17): 4363 - 4368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ochs, R. W. Sobol, S. H. Wilson, and B. Kaina Cells Deficient in DNA Polymerase {beta} Are Hypersensitive to Alkylating Agent-induced Apoptosis and Chromosomal Breakage Cancer Res., April 1, 1999; 59(7): 1544 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Inga, F.-X. Chen, P. Monti, A. Aprile, P. Campomenosi, P. Menichini, L. Ottaggio, S. Viaggi, A. Abbondandolo, B. Gold, et al. N-(2-Chloroethyl)-N-nitrosourea Tethered to Lexitropsin Induces Minor Groove Lesions at the p53 cDNA That Are More Cytotoxic than Mutagenic Cancer Res., February 1, 1999; 59(3): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. He, Y. Xu, M. Kobune, M. Wu, M. R. Kelley, and W. J. Martin II Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L50 - L55. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |